<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="molecules-25-05414-t001" orientation="portrait" position="float">
 <object-id pub-id-type="pii">molecules-25-05414-t001_Table 1</object-id>
 <label>Table 1</label>
 <caption>
  <p>Status of different nanomedicine delivery strategies under development for BJO and/or purified quassinoid encapsulation.</p>
 </caption>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Nanomedicine Class</th>
    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Development Status</th>
    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Main Effects</th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Nanoemulsions</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vivo treatment efficacy in mouse and rat models</td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
     <list list-type="simple">
      <list-item>
       <label>-</label>
       <p>Loaded BJO or pure quassinoid in nanoemulsions with a 20- to 40- nm diameter, and could be developed into liquid or solid formulations.</p>
      </list-item>
      <list-item>
       <label>-</label>
       <p>BJO nanoemulsions had a reduced toxicity in vitro and side effects in vivo compared to BJOE, along with a greater bioavailability and circulation time.</p>
      </list-item>
      <list-item>
       <label>-</label>
       <p>BJO nanoemulsions had a greater treatment performance against cancer cells in vitro and mouse tumors in vivo than BJOE, as well as an improved anti-inflammatory performance in vivo.</p>
      </list-item>
     </list>
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Liposomes</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vivo treatment efficacy in mouse model</td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
     <list list-type="simple">
      <list-item>
       <label>-</label>
       <p>BJO liposomes with a ~110-nm diameter had a lower toxicity and greater circulation time in mice than BJOE.</p>
      </list-item>
      <list-item>
       <label>-</label>
       <p>BJO liposomes had a greater treatment performance against cancer cells in vitro and mouse tumors in vivo than BJOE.</p>
      </list-item>
     </list>
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Nanostructured Lipid Carriers</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro drug release and cancer cell inhibition</td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
     <list list-type="simple">
      <list-item>
       <label>-</label>
       <p>Loaded BJO with stable encapsulation in ~180-nm diameter nanostructures, pH-dependent changes in morphological structure, and slow drug release.</p>
      </list-item>
      <list-item>
       <label>-</label>
       <p>Loaded BJO had a greater inhibitory potency than free BJO and induced cancer cell apoptosis.</p>
      </list-item>
     </list>
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Spongosomes</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro drug release and cancer cell inhibition</td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
     <list list-type="simple">
      <list-item>
       <label>-</label>
       <p>-Loaded BJO with stable encapsulation in 60- to 300-nm diameter nanostructures.</p>
      </list-item>
      <list-item>
       <label>-</label>
       <p>-BJO in spongosomes had a greater inhibitory activity than free BJO.</p>
      </list-item>
     </list>
    </td>
   </tr>
  </tbody>
 </table>
</table-wrap>
